Pizotifen was introduced in mice at the time of isoflurane anesthesia or PSD95-PDZ2 wild-type peptide administration to evaluate its potential in preventing cognitive impairments at 5 weeks of age and loss of mushroom spine density at 7 weeks of age in both male and female mice. Here, DLG4 is linked to Cognitive impairment.